Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 7/20 | 0.54 |
| ▸ | CNR2 | P34972 | 2/20 | 0.51 |
| ▸ | PPARA | Q07869 | 2/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
| ▸ | FTH1 | P02794 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.34 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.32 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17845223 | 1.00 | CYP3A4 (0.54) | CYP3A4CNR2PPARAUSP2FTH1 | |
| SCHEMBL17845218 | 1.00 | CYP3A4 (0.54) | CYP3A4CNR2PPARAUSP2FTH1 | |
| SCHEMBL17841781 | 1.00 | CYP3A4 (0.54) | CYP3A4CNR2PPARAUSP2FTH1 | |
| SCHEMBL29477300 | 0.75 | CYP3A4 (0.61) | CYP3A4CNR2PPARAUSP2FTH1 | |
| SCHEMBL24176358 | 0.75 | CYP3A4 (0.69) | CYP3A4CNR2PPARAUSP2FTH1 | |
| SCHEMBL30808555 | 0.75 | CYP3A4 (0.69) | CYP3A4CNR2PPARAUSP2FTH1 | |
| SCHEMBL11307470 | 0.73 | CYP3A4 (0.77) | CYP3A4CNR2PPARAUSP2FTH1 | |
| SCHEMBL24176161 | 0.73 | CYP3A4 (0.77) | CYP3A4CNR2PPARAUSP2FTH1 | |
| SCHEMBL29978558 | 0.73 | CYP3A4 (0.77) | CYP3A4CNR2PPARAUSP2FTH1 | |
| SCHEMBL24176295 | 0.73 | CYP3A4 (0.77) | CYP3A4CNR2PPARAUSP2FTH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3233780-B1 | 1-(7,10,10-TRIMETHYL-4-BICYCLO(6.2.0)DECANYL)ETHANONE AS NOVEL AROMA CHEMICAL | BASF SE (DE) | 2018-08-01 | — | — | EP | claimed |
| US-9950982-B2 | 1-(7,10,10-trimethyl-4-bicyclo(6.2.0)decanyl)ethanone as novel aroma chemical | BASF SE (REITSTÖTTER, KINZEBACH & PARTNER) (DE) | 2018-04-24 | — | — | US | claimed |
| US-20180002266-A1 | 1-(7,10,10-TRIMETHYL-4-BICYCLO(6.2.0)DECANYL)ETHANONE AS NOVEL AROMA CHEMICAL | BASF SE (DE) | 2018-01-04 | — | — | US | claimed |
| EP-3233780-A1 | 1-(7,10,10-TRIMETHYL-4-BICYCLO(6.2.0)DECANYL)ETHANONE AS NOVEL AROMA CHEMICAL | BASF SE (DE) | 2017-10-25 | — | — | EP | claimed |
| WO-2016097238-A1 | 1-(7,10,10-TRIMETHYL-4-BICYCLO(6.2.0)DECANYL)ETHANONE AS NOVEL AROMA CHEMICAL | BASF SE (DE) | 2016-06-23 | — | — | WO | claimed |
| EP-3233780-B1 | 1-(7,10,10-TRIMETHYL-4-BICYCLO(6.2.0)DECANYL)ETHANONE AS NOVEL AROMA CHEMICAL | BASF SE (DE) | 2018-08-01 | — | — | EP | disclosed |
| US-9950982-B2 | 1-(7,10,10-trimethyl-4-bicyclo(6.2.0)decanyl)ethanone as novel aroma chemical | BASF SE (REITSTÖTTER, KINZEBACH & PARTNER) (DE) | 2018-04-24 | — | — | US | disclosed |
| US-20180002266-A1 | 1-(7,10,10-TRIMETHYL-4-BICYCLO(6.2.0)DECANYL)ETHANONE AS NOVEL AROMA CHEMICAL | BASF SE (DE) | 2018-01-04 | — | — | US | disclosed |
| EP-3233780-A1 | 1-(7,10,10-TRIMETHYL-4-BICYCLO(6.2.0)DECANYL)ETHANONE AS NOVEL AROMA CHEMICAL | BASF SE (DE) | 2017-10-25 | — | — | EP | disclosed |
| WO-2016097238-A1 | 1-(7,10,10-TRIMETHYL-4-BICYCLO(6.2.0)DECANYL)ETHANONE AS NOVEL AROMA CHEMICAL | BASF SE (DE) | 2016-06-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180002266-A1 | 1-(7,10,10-TRIMETHYL-4-BICYCLO(6.2.0)DECANYL)ETHANONE AS NOVEL AROMA CHEMICAL | OR10J3, TAS2R10, TAS2R50 | CYP3A4 876/4885CNR2 148/4885PPARA 1821/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.